Evidence map›Paper›PMID 34943747›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Inhibition of MurA Enzyme from

Macarena Funes Chabán, Martina Hrast, Rok Frlan, Dafni G Graikioti, Constantinos M Athanassopoulos, María Cecilia Carpinella

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. TheFrontiers in microbiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Macarena Funes ChabánFine Chemical and Natural Products Laboratory, IRNASUS CONICET-UCC, Universidad Católica de Córdoba, Córdoba 5016, Argentina.
Martina HrastFaculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.ORCID 0000-0003-0488-2445
Rok FrlanFaculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.ORCID 0000-0003-0956-5537
Dafni G GraikiotiSynthetic Organic Chemistry Laboratory, Department of Chemistry, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-8057-0019
Constantinos M AthanassopoulosSynthetic Organic Chemistry Laboratory, Department of Chemistry, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-7549-1911
María Cecilia CarpinellaFine Chemical and Natural Products Laboratory, IRNASUS CONICET-UCC, Universidad Católica de Córdoba, Córdoba 5016, Argentina.ORCID 0000-0001-5553-1851
Universidad Católica de Córdoba · ARUniversity of Ljubljana · SIUniversity of Patras · GR

Funding

Catholic University of CórdobaFondo Nacional de Ciencia Tecnología e Innovación PICT 2017-1381Fondo Nacional de Ciencia Tecnología e Innovación PICT 2019-2019-00721National Scientific and Technical Research Council PIP 2014-2016National Scientific and Technical Research Council PIP- 2021-2023Slovenian Research Agency P1-0208University of Patras
6 · The paper itself

Abstract

Enzymes MurA and MurF, involved in bacterial cell wall synthesis, have been validated as targets for the discovery of novel antibiotics. A panel of plant-origin antibacterial diterpenes and synthetic analogs derived therefrom were investigated for their inhibitory properties on these enzymes from

Indexed as

dehydroabietane derivativesditerpenesEscherichia coli MurAMurA and MurF inhibitorsStaphylococcus aureus MurA

Identifiers

PMID34943747
PMCPMC8698320
OpenAlexW4200248345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.